Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.
$12.15 -1.17 (-8.78%)
As of 03/02/2021 15:59:53 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.